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Abstract
Purpose Polyphenolic curcumin is known to have potent
anti-inflammatory effects; thus the present study investigated the hypothesis that curcumin ingestion would attenuate muscle damage after eccentric exercise.
Methods Fourteen untrained young men (24 ± 1 years)
performed 50 maximal isokinetic (120°/s) eccentric contractions of the elbow flexors of one arm on an isokinetic
dynamometer and the same exercise with the other arm
4 weeks later. They took 150 mg of curcumin (theracurmin) or placebo (starch) orally before and 12 h after each
eccentric exercise bout in a randomised, crossover design.
Maximal voluntary contraction (MVC) torque of the elbow
flexors, range of motion of the elbow joint, upper-arm circumference, muscle soreness, serum creatine kinase (CK)
activity, and plasma interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) concentration were measured before,
immediately after, and 24, 48, 72 and 96 h after each
eccentric exercise. Changes in these variables over time
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were compared between curcumin and placebo conditions
by two-way repeated measures ANOVA.
Results MVC torque decreased smaller and recovered faster (e.g., 4 days post-exercise: −31 ± 13 % vs.
−15 ± 15 %), and peak serum CK activity was smaller
(peak: 7684 ± 8959 IU/L vs. 3398 ± 3562 IU/L) for curcumin than placebo condition (P < 0.05). However, no
significant differences between conditions were evident
for other variables, and no significant changes in IL-6 and
TNF-α were evident after exercise.
Conclusion It is concluded that theracurmin ingestion
attenuates some aspects of muscle damage such as MVC
loss and CK activity increase.
Keywords Polyphenolic · Elbow flexors · Muscle
strength · Muscle soreness · Supplement · Creatine kinase
Abbreviations
CK	Creatine kinase
DOMS	Delayed onset muscle soreness
IL-6	Interleukin 6
MVC	Maximal voluntary contraction
ROM	Range of motion
TNF-α	Tumor necrosis factor-α
VAS	Visual analog scale

Introduction
Unaccustomed exercise, especially that consists of highintensity and/or large number of eccentric (lengthening)
contractions, induces muscle damage (Clarkson et al.
1992). Eccentric exercise-induced muscle damage is indicated by prolonged decreases in muscle strength and range
of motion (ROM), swelling, delayed onset muscle soreness
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(DOMS), and increased muscle proteins in the blood such
as creatine kinase (CK) activity (Warren et al. 1999). Muscle damage initiates inflammatory responses, resulting in
secondary muscle damage (Tiidus 1998). The impairment
of muscle function caused by damage and subsequent
inflammatory responses could reduce the ability to perform
daily activities and athletic performance. Thus, it is important to prevent or minimise muscle damage after exercise
by attenuating inflammatory responses. One of many measures for this purpose could be an oral intake of anti-inflammatory substances (Connolly et al. 2003).
Several studies have shown that some anti-inflammatory
substance supplementations are beneficial for attenuating
eccentric exercise-induced muscle damage (Connolly et al.
2006; Howatson et al. 2010; Trombold et al. 2010), but
other did not find such effect (O’Fallon et al. 2012). These
inconsistent results may, in part, be due to the differences in
substances, exercise model and experimental design among
studies. It has been reported that tart cherry juice consumption enhanced recovery of muscle strength and attenuated
interleukin-6 (IL-6) and C-reactive protein responses after
marathon running (Howatson et al. 2010) and prolonged
upper arm exercise (Connolly et al. 2006). Other study
showed that taking polyphenol ellagitannins from pomegranate extract before and after high-intensity elbow flexor
eccentric exercise attenuated muscle strength loss by 10 %
(Trombold et al. 2010). In contrast, O’Fallon et al. (2012)
reported that ingestion of a polyphenol flavonoid from
quercetin before and after exercise did not affect changes
in maximal voluntary contraction (MVC) strength, ROM,
serum CK activity, IL-6 and tumor necrosis factor-α (TNFα) and DOMS after elbow flexor eccentric contractions.
Curcumin, extracted from turmeric, is a natural polyphenolic substance. It has been demonstrated that curcumin has anti-inflammatory effect by downregulating the
nuclear factor-kappa B (NF-kB), thereby suppressing the
expression of IL-6 and TNF-α (Cho et al. 2007; Aggarwal
et al. 2006). The anti-inflammatory effects of curcumin
have been used in the treatment of rheumatoid arthritis,
inflammatory bowel disease, multiple sclerosis and diabetes (Sethi et al. 2009). Usharani et al. (2008) demonstrated
that 600 mg of daily curcumin intake for 8 weeks reduced
approximately 60 % of plasma IL-6 and TNF-α concentrations in diabetes mellitus patients. Polyphenol supplementation of curcumin has been reported to blunt IL-6 and
TNF-α increases in mice muscle after downhill running
(Davis et al. 2007). Kawanishi et al. (2013) have recently
reported that oral curcumin ingestion (3 mg) suppresses
oxidative stress, reducing hydrogen peroxide in skeletal
muscle following downhill running-induced muscle damage in mice. Thus, it is possible that curcumin supplementation is effective for attenuating eccentric exercise-induced
muscle damage in humans. However, to the best of our
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knowledge, no previous human study has examined the
effects of curcumin ingestion on markers of muscle damage
after eccentric exercise.
The purpose of this study, therefore, was to examine
the acute effect of curcumin intake before and 12 h postexercise on changes in indirect markers of muscle damage
and inflammation after eccentric elbow flexors exercise. It
was hypothesised that curcumin ingestion would attenuate
the changes in indirect muscle damage markers and inflammatory markers in the blood after eccentric exercise when
compared with placebo condition.

Methods
Subjects
The present study recruited 14 healthy, untrained young
men who had not been involved in any regular resistance
training for at least 1 year before this study. Their average ± SD age, height and body mass were 23.5 ± 2.3 years,
172.1 ± 7.5 cm and 65.2 ± 11.3 kg, respectively. The sample size was estimated on the assumption that the curcumin
ingestion could attenuate the decrease in muscle strength in
recovery days by at least 25 %, if it was effective. On the
basis of the power of 0.80 and alpha level of 0.05, a sample
size of 10 was found to be necessary based on the data of a
previous study (Evans et al. 2002) in which a similar eccentric exercise to that of the present study was performed.
Subjects maintained their normal food intake and lifestyle
habits, but abstained from strenuous physical activities,
and did not take anti-inflammatory drugs during the study
period. All subjects gave their written informed consent to
participate in the study, and all procedures were reviewed
and approved by the ethical committee of the University of
Tsukuba.
Experimental design
This study used a crossover design in which one arm was
used for curcumin condition, and the other arm was used
for placebo condition in a randomised, single-blinded fashion. This design requires a smaller number of participants,
and it has been reported that a within-subject (contralateral
arm) design is an alternative to a between-subject design if
the order of exercise is counterbalanced by arm dominance
(Newton et al. 2013).
Each arm performed a bout of eccentric exercise of the
elbow flexors separated by 4 weeks, and the use of dominant-nondominant arms and the order of the conditions
were counterbalanced among the subjects. Dependent
variables consisted of MVC torque of the elbow flexors,
ROM of the elbow joint, upper-arm circumference, muscle
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soreness, serum CK activity, and plasma IL-6 and TNF-α
concentrations. Changes in these variables before, immediately after and 24, 48, 72 and 96 h after the exercise were
compared between the curcumin and placebo conditions.
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the elbow extending action of the dynamometer for the
whole range of motion. Total work and peak torque were
calculated using the BIODEX System software.
Muscle damage markers

Curcumin and placebo
We developed theracurmin (Theravalues Corporation,
Japan) using a microparticulation and surface processing technique, and theracurmin has been shown to result
in much higher plasma concentration and bioavailability after intake when compared with conventional curcumin powder (Sasaki et al. 2011). As a placebo, starch
was used, which was contained in an identical capsule as
that of the curcumin, so the subjects could not distinguish
between them. Six capsules of 25 mg of curcumin or placebo were administered 1 hour before (150 mg) and 12 h
after exercise (150 mg). It has been reported that postexercise inflammation starts to present around 4–12 h after
eccentric exercise, and further develops in 24–48 h after
exercise (Paulsen et al. 2012; Davis et al. 2007). Considering the time taken for the curcumin to get into the blood
stream, and its remaining time in the blood, it was assumed
that the ingestion at 1 h before exercise could attenuate the
initial inflammation, and that at 12 h after exercise could
attenuate the development of inflammation before 24 h
post-exercise. The amount (150 mg) has been shown to be
safe for one time dose (Kanai et al. 2012). However, it had
not been known before this study how much of curcumin
would be effective to prevent muscle damage in humans,
so we assumed that a significant difference between the
curcumin and placebo conditions would be shown by the
dose (150 mg before and 12 h after exercise, 300 mg/day),
if any positive effect of curcumin ingestion on muscle damage existed.
Eccentric exercise
All subjects performed two bouts of eccentric exercise of
the elbow flexors on a BIODEX dynamometer (BIODEX
System 3, USA), using one arm for each bout separated
by 4 weeks. Each subject was seated on the dynamometer chair with the arm being supported by padded armrest
secured at 45° shoulder flexion and the waist and chest
being stabilised with straps. The exercise consisted of 50
maximal eccentric contractions of the elbow flexors at an
angular velocity 120°/s, and the range of motion was from
130° and to 10° elbow flexion, where a fully extended
elbow joint angle was considered to be 0°, thus each contraction time was 1 s (Evans et al. 2002). The exercise limb
was passively returned to the initial position at 10°/s, creating a 12-s rest between contractions. The subjects were
instructed to contract the elbow flexors maximally to resist

Several indirect markers of muscle damage, which were
often used in previous studies (Nosaka et al. 2002a, b),
were measured before, immediately after, and 24, 48, 72
and 96 h after each exercise bout. The details of the markers are shown below. The test–retest reliability of each
measure was determined using two baseline measurements
performed before exercise by an interclass correlation coefficient (R) and coefficient of variation (CV). The R and CV
(shown in parentheses) values for MVC torque, ROM and
upper-arm circumference were 0.99 (2.9 %), 0.97 (1.1 %)
and 1.00 (0.2 %), respectively. The muscle soreness was
not assessed for the reliability, because all participants
recorded DOMS scores as zero for palpation during the
familiarisation sessions. The intra-assay CV was 5.3 % for
CK activity, 3.2 % for IL-6 and 10.0 % for TNF-α in a pilot
study using five men.
MVC torque
MVC torque of the exercised elbow flexors was measured
using the isokinetic dynamometer in the same positioning
as that of the eccentric exercise, and the elbow joint angle
was set at 90°. Three 5-s maximal isometric contractions
were performed with a 30-s rest between trials, and the
highest value of the three trials was used for further analysis (Nosaka et al. 2002a).
ROM
According to the protocol of the previous study (Nosaka
et al. 2006), each subject was asked to actively extend the
elbow joint maximally (extended elbow joint angle) and
to touch shoulder of the same side with the hand (flexed
elbow joint angle). The ROM was determined as the difference between the two elbow joint angles. Each angle was
measured by a goniometer three times, and the mean of the
three measures was used for the calculation of ROM.
Upper‑arm circumference
To assess muscle swelling, upper-arm circumference was
assessed at the mid-belly of biceps brachii muscle (60 %
distal to the length between the acromial process and epicondylus lateralis humeri) using a standard tape measure
(Evans et al. 2002). The measurements were taken three
times, and mean value of the three measurements was used
for further analysis.
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Muscle soreness
Muscle soreness upon palpation of the upper-arm and passively extending the elbow joint was quantified by a visual
analog scale (VAS) that had a 100-mm line with “no pain”
on one end and “extremely sore” on the other end (Chen
and Nosaka 2006). The subjects were instructed to sit with
arm relaxed, and the investigator palpated over the biceps
brachii, and extended the elbow joint maximally. The same
investigator performed all tests and the pressure of palpation was kept as constant as possible between subjects and
between days.
Blood sampling and analyses
Blood was taken from the antecubital vein by a standard venipuncture technique. To obtain serum for CK
activity analysis, 9 ml blood sample was collected using
commercially produced vacuum-sealed serum collection tube (SEKISUI Medical Company Limited, Japan).
To obtain the plasma for curcumin, IL-6, and TNF-α
analyses, 5 ml blood sample was collected using a tube
containing ethlenediaminetetraacetic acid (Terumo corporation, Japan). These were centrifuged at 3000 rpm
for 15 min at 4 °C, and the serum and plasma samples
were stored at −80 °C until analysis. Plasma curcumin
concentration was measured by a HPLC–MS/MS system consisting of a Prominence micro-C system (Shimadzu, Kyoto, Japan) and an API 3200 tandem mass
spectrometer (Applied Biosystems CA, USA). Serum
CK activity was measured using a test kit (L-type CK,
Wako Pure Chemical Industries, Japan) by a commercial laboratory. The normal reference range for male
adults with this method is 48–259 IU/L. The concentrations of plasma IL-6 and TNF-α were determined using
a commercial enzyme-linked immunosorbent assay kit
(Quantikine Human IL-6, TNF-α R & D system Inc.
Minneapolis, USA).
Statistical analyses
Changes in the dependent variables over time were compared between the curcumin and placebo conditions by a
two-way repeated-measures ANOVA. When the ANOVA
showed a significant interaction effect, a Tukey’s post hoc
test was used to locate differences between conditions. A
Tukey’s post hoc test was also used to compare the preexercise and post-exercise values for each bout separately,
when a significant time effect was found by the ANOVA.
Inter-group comparison for the total work and mean eccentric peak torque during the exercise were made by a paired
t test. Since a Kolmogorov-Smirov test showed that serum
CK activity data was not normally distributed, the peak
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Fig. 1  Changes (mean ± SD) in plasma curcumin concentration
from the baseline (Pre), immediately (0) and 24–96 h after eccentric exercise of the elbow flexors for the curcumin and placebo supplementation conditions. *P < 0.05 vs. Pre; †P < 0.05 vs. placebo;
P < 0.05: a significant interaction effect

serum CK activity was compared between the condition
using a non-parametric Wilcoxon’s rank test. The level
of statistical significance was set at P < 0.05. All data are
shown as mean ± standard deviation (SD).

Results
Plasma curcumin concentration
There was no difference in plasma curcumin concentration at baseline between curcumin and placebo conditions, but a significant interaction effect was evident for
the changes after exercise (Fig. 1). Plasma curcumin concentration increased from baseline (0.04 ± 0.07 ng/mL)
to 127.7 ± 144.6, 85.7 ± 51.6, 8.6 ± 5.5, 2.2 ± 1.4 and
0.9 ± 0.6 ng/mL at 0, 24, 48, 72 and 96 h after exercise,
respectively, for the curcumin condition. However, in the
placebo condition, no significant changes in plasma curcumin concentration were observed from the baseline
(0.01 ± 0.05 ng/mL) at any time points after exercise
(0.02 ± 0.05, 0.02 ± 0.04, 0.03 ± 0.08, 0.03 ± 0.04 and
0.01 ± 0.02 ng/mL at 0, 24, 48, 72 and 96 h post-exercise,
respectively).
Exercise
The total work (2815 ± 788 J vs. 3011 ± 756 J, P = 0.178)
and mean peak torque (40 ± 11 Nm vs. 41 ± 9 Nm,
P = 0.597) during eccentric exercise did not differ between
curcumin and placebo conditions.

Eur J Appl Physiol (2015) 115:1949–1957
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MVC torque
The MVC torque before exercise was not significantly different between curcumin (52.5 ± 10.3 Nm) and placebo
(55.1 ± 8.8 Nm) conditions. As shown in Fig. 2, a significant interaction effect was evident for the changes in MVC
torque. The change in MVC from baseline was significantly smaller for the curcumin condition (33.0 ± 8.0 %)
compared with placebo condition (40.0 ± 9.1 %) at immediately after exercise and also at 48–96 h after exercise by
13–16 %.
ROM
At the baseline, ROM was similar between curcumin
(134° ± 4°) and placebo (133° ± 5°) conditions. After
eccentric exercise, ROM significantly decreased at all
measurement time points from the baseline, but no significant interaction effect was evident for the changes between
conditions (Fig. 3).

Fig. 2  Normalised changes (mean ± SD) in maximal voluntary isometric contraction (MVC) torque from the baseline (Pre), at immediately (0) and 24–96 h after eccentric exercise of the elbow flexors for
the curcumin and placebo supplementation conditions. *P < 0.05 vs.
Pre; †P < 0.05 vs. placebo; P < 0.05: a significant interaction effect

Upper‑arm circumference
There was no significant difference in the baseline upperarm circumference between curcumin (25.7 ± 2.5 cm) and
placebo (25.9 ± 2.8 cm) conditions. Upper-arm circumference significantly increased after exercise by 3 % at 96 h
post-exercise for both conditions, but no significant differences between conditions were found (Fig. 4).
Muscle soreness
Significant increases in VAS were observed between 24 and
96 h after eccentric exercise for both conditions, and the
peak VAS upon palpation was 5.5 ± 2.1 cm for curcumin
and 6.0 ± 2.2 cm for placebo condition, but no significant
interaction effect was evident (Fig. 5). This was also the
case for the VAS with elbow joint extension, and the values
were similar to those shown by the palpation.
Serum CK activity
Serum CK activity was within normal reference range
prior to exercise without any significant difference
between the curcumin (118 ± 49 IU/L) and control
(115 ± 47 IU/L) conditions. Although the changes in
serum CK activity after eccentric exercise were not statistically different between conditions (Fig. 6, P = 0.052),
peak CK activity was significantly smaller for curcumin
condition (3398 ± 3562 IU/L) than placebo condition
(7684 ± 8959 IU/L).

Fig. 3  Absolute changes (mean ± SD) in range of motion (ROM)
from the baseline (Pre) at immediately (0) and 24–96 h after eccentric
exercise of the elbow flexors for the curcumin and placebo supplementation conditions. *P < 0.05 vs. Pre; NS no significant interaction
effect

Plasma IL‑6 and TNF‑α concentration
Plasma IL-6 and TNF-α concentrations were not different between groups before exercise (IL-6 0.83 ± 0.22 vs.
0.73 ± 0.18 ng/mL, TNF-α 1.85 ± 0.74 vs. 1.63 ± 0.35 ng/
mL, for curcumin and placebo, respectively). They did not
change significantly after eccentric exercise, and no significant differences were found between curcumin and placebo
conditions (Fig. 7).
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Fig. 4  Absolute changes (mean ± SD) in upper-arm circumference
(CIR) from the baseline (Pre) at immediately (0) and 24–96 h after
eccentric exercise of the elbow flexors for the curcumin and placebo
supplementation conditions. *P < 0.05 vs. Pre; NS no significant
interaction effect

Eur J Appl Physiol (2015) 115:1949–1957

Fig. 6  Changes (mean ± SD) in serum CK activity before (Pre),
immediately after (0) and 24–96 h after eccentric exercise of the
elbow flexors for the curcumin and placebo supplementation conditions. *P < 0.05 vs. Pre; An inset, peak serum CK activity for the curcumin (C) and placebo (P) conditions is shown; †P < 0.05 vs. placebo

Fig. 5  Muscle soreness upon palpation of biceps brachii
(mean ± SD) assessed by a visual analog scale (10 cm) before (Pre),
immediately after (0) and 24–96 h after eccentric exercise of the
elbow flexors for the curcumin and placebo supplementation conditions. *P < 0.05 vs. Pre; NS no significant interaction effect

Discussion
This study investigated whether curcumin (theracurmin)
ingestion at 1 h before and 12 h after eccentric exercise
would attenuate muscle damage in healthy young men. The
main findings of the study include that (1) plasma curcumin
concentration elevated from the baseline after exercise
only for curcumin condition (Fig. 1); (2) the magnitude
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Fig. 7  Changes (mean ± SD) in plasma IL-6 (a) and TNF-α (b)
concentrations before (Pre), immediately after (0) and 24–96 h after
eccentric exercise of the elbow flexors for the curcumin and placebo
supplementation conditions. NS no significant interaction effect

Eur J Appl Physiol (2015) 115:1949–1957

of decrease in MVC torque was significantly smaller for
curcumin than placebo condition (Fig. 2), (3) peak serum
CK activity was significantly reduced in the curcumin than
placebo condition (Fig. 6), but (4) no significant differences between the conditions were evident for other variables (Figs. 3, 4, 5, 7). These results did not fully support
the hypothesis that curcumin ingestion would attenuate the
changes in the muscle damage markers after eccentric exercise, but showed that the curcumin was effective for some
aspects of muscle damage.
The present study used an arm-to-arm comparison
model, and the test order of curcumin and placebo conditions, as well as the use of the dominant and nondominant
arms, were counterbalanced among subjects. The total work
and mean peak torques during eccentric exercise did not differ between conditions. Although a small (7 %) non-significant difference in the total work was observed between the
conditions, the total work did not correlate with the magnitude of decrease in MVC torque. Thus, it seems reasonable
to expect that changes in the dependent variables were similar between the conditions, if curcumin ingestion had not
produced any effects. However, the magnitude of decline
in MVC torque immediately after exercise for the curcumin
condition (33 %) was significantly smaller than that of the
placebo condition (40 %), and this difference was sustained
in the recovery days (Fig. 2). These indicate that the curcumin ingestion immediately before and/or 12 h after exercise affected the changes in MVC torque.
Trombold et al. (2010) showed that daily ellagitannin
intake reduced loss of isometric elbow flexion strength by
10 % at 48 and 72 h after exercise. Connolly et al. (2006)
reported that cherry juice ingestion for 4 days before and
for 4 days after exercise attenuated muscle strength loss by
20 %. These authors speculated that anti-inflammatory and/
or anti-oxidant effect of the substances decreased secondary muscle damage responses such as increases in vascular
permeability, neutrophil and free radical, attenuating muscle fibre disruption (Connolly et al. 2006; Trombold et al.
2010). It is important to note that increases in serum CK
activity were also attenuated by the curcumin ingestion in
the present study (Fig. 6). Increases in CK activity in the
blood indicate disruption of plasma membrane of muscle
fibres and are commonly used as a marker of muscle fibre
damage (Clarkson et al. 1992). It was reported that morphological disruption of myofibrils was associated with the
magnitude of decrease in muscle function (Raastad et al.
2010). In the present study, the smaller increases in serum
CK activity in the curcumin condition compared with the
placebo condition may suggest that myofibril damage was
attenuated by curcumin ingestion. This might be associated
with the smaller decreases in MVC torque for the curcumin
condition. Moriyuki et al. (2010) reported that curcumin
inhibited production of prostaglandin via suppression
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of cyclooxygenase-2 upregulation and NF-kB signals,
implying that curcumin ingestion might decrease vascular
permeability. It may be that curcumin stabilises plasma
membrane, which might be associated with the attenuated
increase in serum CK activity and decrease in MVC torque
after eccentric exercise. It is necessary to investigate the
effects of curcumin on plasma membrane and myofibrils
damage in future studies.
The present study found that curcumin ingestion had no
positive effects on ROM (Fig. 3), swelling (Fig. 4), DOMS
(Fig. 5) and blood markers (IL-6 and TNF-α) of inflammation (Fig. 7). Changes in ROM, upper-arm circumference
and DOMS after eccentric exercise were similar to those
reported in previous studies (Evans et al. 2002; Nosaka
et al. 2006). It was expected that curcumin ingestion would
reduce the magnitude of decrease in ROM and increase
in upper-arm circumference and DOMS; however, no
such effects were found (Figs. 3, 4, 5). Davis et al. (2007)
showed curcumin ingestion (10 mg) in mice (considering the body weight difference, it would be 10,000 mg in
human) attenuated IL-6 and TNF-α elevation following
eccentric exercise. Comparing to this animal study, the
amount of curcumin (150 mg × 2) was small in the present
study. However, it is known that curcumin is highly lipophilic and poorly bioavailabe, and that more than 8000 mg
of curcumin intake did not necessarily increase blood curcumin concentration in human (Kanai et al. 2012). In contrast, the theracurmin that was used in the present study
was highly absorbable and more bioavailable when compared with conventional curcumin powder (Sasaki et al.
2011). It is not known how equivalent the amount of theracurmin used in the present study (150 mg × 2) was to that
of the previous studies that used conventional curcumin
powder (e.g. 8000 mg). The subjects ingested theracurmin
before exercise and 12 h after exercise, which resulted in
prolonged increases in plasma curcumin concentration
above the baseline for 96 h after exercise for the curcumin
condition, although the level of plasma curcumin concentration was low (8 < ng/mL) at 48–96 h post-exercise
(Fig. 1). Although the range of the subject’s body mass
was relatively large (50–91 kg), there was no relationship between plasma curcumin concentration and body
mass. A previous study showed that ingestion of theracurmin (150 mg) increased plasma curcumin concentration
already at 1 h post-ingestion, and its half-life time was 12 h
in healthy adults (Kanai et al. 2012). Thus, it is assumed
that the amount of curcumin for each time point (150 mg)
was adequate to provide anti-inflammatory effects, if the
supplement had such effects. However, the present study
found a significant effect of theracurmin supplementation
before and after exercise on MVC torque and CK activity
only, and no effects on ROM, muscle soreness and swelling. Nosaka et al. (2006) reported that essential amino acid
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supplementation given 30 min before and immediately after
eccentric exercise (total of 7.2 g) did not affect any indicators of muscle damage, but when the supplementation
was continued in next 4 days after exercise (morning and
evening for ten times over 5 days, total of 36 g) attenuated
increase in muscle soreness and ROM. Thus, it is possible
that the effects of curcumin supplementation on DOMS
and swelling would have been found, if the curcumin had
been given on recovery days (e.g. 1–4 days post-exercise).
There are many possible supplementation conditions in
terms of dose, frequency and time points; a series of studies are warranted to investigate whether a larger dose and
more frequent theracurmin supplementation in recovery
days after eccentric exercise will provide greater effects on
muscle damage.
The polyphenolic component of curcumin exerts antiinflammatory effects via downregulation of NF-κB, which
decreases in the expression of inflammatory cytokines
such as IL-6 and TNF-α (Jobin et al. 1999; Shishodia et al.
2007; Davis et al. 2007). Thus, we expected to see smaller
increases in IL-6 and TNF-α after eccentric exercise for the
curcumin than placebo condition; however, no significant
differences between conditions were found, and they did
not change significantly for either condition (Fig. 7). Hirose
et al. (2004) showed no significant changes in IL-6 and
TNF-α at 24–96 h after elbow flexor eccentric exercise and
explained that the short exercise time and the small muscle
mass involved in the exercise did not affect the inflammatory cytokine levels in the blood. Philippou et al. (2009)
reported that knee extensor eccentric contractions increased
serum IL-6 concentrations at 6 and 48 h post-exercise, but
Miles et al. (2008) showed that IL-6 increased at 8 and 12 h,
and returned to the baseline level at 24 h after elbow flexor
eccentric exercise. Depner et al. (2010) reported that TNF-α
concentration did not change, but IL-6 decreased by 20 %
at 1.5 and 4 h after eccentric exercise of the elbow flexors and extensors. Thus, it might be that the present study
missed the changes in IL-6 and TNF-α, because no blood
samples were taken between immediately and 24 h after
exercise. It is also interesting to assess other cytokines (e.g.
IL-8, IL-10) and inflammatory markers (e.g. C-reactive protein) in future studies. Previous animal studies have reported
that curcumin ingestion attenuated increases in inflammatory cytokine (e.g., IL-6 and TNF-α) in the soleus muscle
and oxidative stress markers (e.g., hydrogen peroxide and
NADPH-oxidase) in the gastrocnemius muscle at 24 and
48 h after downhill running (Davis et al. 2007; Kawanishi
et al. 2013). Therefore, it is also important to examine the
effects of curcumin ingestion on inflammatory cytokines
and oxidative stress marker in human skeletal muscles.
Many studies that investigated the effect of nutritional
supplementation on muscle function have failed to find
positive effect on muscle function (Nosaka et al. 2006;
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Bryer and Goldfarb 2006; O’Fallon et al. 2012). However, the present study demonstrated that highly bioavailable curcumin attenuated the loss of muscle function after
eccentric exercise. This may be important for athletes who
train and compete regularly, since curcumin ingestion could
help them to reduce prolonged loss of muscle function in
an intense competition season. However, it should be noted
that the present study used untrained men as the subjects
and thus the findings of the present study cannot be generalised to other population such as women and trained
individuals. Further studies are necessary to test women
and trained individuals for the effects of curcumin supplementation on eccentric exercise-induced muscle damage.
Furthermore, if curcumin supplementation provides strong
anti-inflammatory effects, it should be investigated whether
chronic curcumin intake attenuates muscle adaptations
induced by resistance training. Trappe et al. (2001) reported
that ibuprofen blunted protein synthesis after knee extensor
eccentric exercise. Thus, it might be that chronic consumption of curcumin blunts muscle hypertrophy. The chronic
supplementation of curcumin warrants further studies.
In conclusion, the present study demonstrated that the
decrease in muscle strength and increase in serum CK activity after eccentric exercise were attenuated by highly bioavailable curcumin intake at 1 h before and 12 h after eccentric
exercise of the elbow flexors in untrained men. These findings
suggest that curcumin intake has some beneficial effects on
recovery of eccentric exercise-induced muscle damage.
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